Loading clinical trials...
Loading clinical trials...
Multicentre Randomised Phase II Trial of Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients (=/> 70 Years) With Advanced Non-Small Cell Lung Cancer
Conditions
Interventions
Erlotinib
Vinorelbine and Carboplatin
Locations
40
Germany
Gemeinschaftspraxis
Augsburg, Germany
Zentralklinik Bad Berka GmbH
Bad Berka, Germany
Charité - Campus Benjamin Franklin
Berlin, Germany
Helios Klinikum Emil von Behring
Berlin, Germany
Evangelische Lungenklinik Berlin
Berlin, Germany
Evang. Krankenhaus Bielefeld
Bielefeld, Germany
Start Date
June 1, 2006
Primary Completion Date
November 1, 2008
Last Updated
May 16, 2008
NCT06305754
NCT07190248
NCT07100080
NCT07195695
NCT06357533
NCT06731413
Lead Sponsor
LungenClinic Grosshansdorf
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions